{"id":"NCT02545543","sponsor":"Seqirus","briefTitle":"A Study to Evaluate the Immunogenicity and Safety of Seqirus Quadrivalent Influenza Vaccine (QIV) in a Pediatric Population 5 Through 17 Years of Age","officialTitle":"A Phase 3, Randomized, Multicenter, Observer-Blinded, Noninferiority Study to Evaluate the Immunogenicity and Safety of a Seqirus Quadrivalent Inactivated Influenza Virus Vaccine (Seqirus QIV) With a US-Licensed 2015-2016 Quadrivalent Inactivated Comparator Influenza Vaccine (Comparator QIV) in a Pediatric Population 5 Through 17 Years of Age","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2015-09","primaryCompletion":"2016-01","completion":"2016-06","firstPosted":"2015-09-10","resultsPosted":"2017-04-18","lastUpdate":"2018-05-23"},"enrollment":2278,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"QUADRUPLE","primaryPurpose":"PREVENTION"},"conditions":["Influenza, Human"],"interventions":[{"type":"BIOLOGICAL","name":"Seqirus QIV","otherNames":[]},{"type":"BIOLOGICAL","name":"Comparator QIV","otherNames":["Fluarix Quadrivalent"]}],"arms":[{"label":"Seqirus Quadrivalent Inactivated Influenza Vaccine","type":"EXPERIMENTAL"},{"label":"Comparator Quadrivalent Influenza Vaccine","type":"ACTIVE_COMPARATOR"}],"summary":"This is a study to assess the immune (antibody) response and safety of a Seqirus split virion, inactivated Quadrivalent Influenza Vaccine (Seqirus QIV), in comparison with a US licensed 2015/2016 Quadrivalent Influenza Vaccine (comparator QIV) in a healthy pediatric population 5 through 17 years of age.","primaryOutcome":{"measure":"The Geometric Mean Titer (GMT) Ratio of Each Virus Strain.","timeFrame":"28 days after last vaccination.","effectByArm":[{"arm":"GMT Ratios: GMT Comparator QIV Over GMT Seqirus QIV","deltaMin":1.01,"sd":null}],"pValues":[]},"eligibility":{"minAge":"5 Years","sex":"ALL","healthyVolunteers":true,"inclusionCount":3,"exclusionCount":14},"locations":{"siteCount":32,"countries":["United States"]},"refs":{"pmids":["28390934"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":8,"n":1692},"commonTop":["Pain","Redness","Headache","Swelling","Myalgia"]}}